<?xml version="1.0" encoding="UTF-8"?>
<p>Indeed, there is no doubt that the latter are involved in modulating disease onset and progression. For example, early studies report that, similarly with what was observed with SARS-CoV, lymphopenia [sometimes equivalent or more severe than that observed in human immunodeficiency virus (HIV) infection] is often observed in severely affected patients progressing to ARDS. Despite, or maybe correlated with this, aberrant non-effective innate immune host responses seem associated with severe lung disease during SARS (
 <xref rid="B6" ref-type="bibr">6</xref>â€“
 <xref rid="B12" ref-type="bibr">12</xref>).
</p>
